Thromboelastography: A tool for measuring hypercoagulability, hypocoagulability, and fibrinolysis

Journal of Veterinary Emergency and Critical Care

Volumn 15, Issue 1, 2005, Pages 9-16

  Donahue, Suzanne M ^a   Otto, Cynthia M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Coagulation; Disseminated in travascular coagulation; Heparin; Monitoring; Thrombosis

Indexed keywords

ANIMALIA; CANIS FAMILIARIS; PARVOVIRUS;

EID: 27744574254     PISSN: 14793261     EISSN: 14764431     Source Type: Journal    
DOI: 10.1111/j.1476-4431.2005.04025.x     Document Type: Review

References (82)

1. Whalen J, Tuman K. Monitoring hemostasis. Int Anesthesiol Clin 1996; 34(3):195-213.
2. Brooks J. Coagulopathies and thrombosis, In: Ettinger SJ, Felman EC. eds. Textbook of Veterinary Internal Medicine, 5th edn. Philadelphia: WB Saunders; 2000, pp. 1829-1841.
3. Opal S, Kesller C, Roemisch J, et al. Antithrombin, heparin, and heparan sulfate. Crit Care Med 2002; 30(5):S325-S331.
4. Esmon C. Protein C anticoagulant pathway and its role in controlling microvascular thrombosis and inflammation. Crit Care Med 2001; 29(7):S48-S51.
5. Lijnen HR, Collen D. Molecular and cellular basis of fibrinolysis, In: Hoffman R. ed. Hematology: Basic Principles and Practice. New York: Churchill-Livingstone; 2000, pp. 1804-1805.
6. Rasedee A, Feldman BF, Washabau R. Naturally occurring canine nephrotic syndrome is a potentially hypercoagulable state. Acta Vet Scand 1986; 27:369-377.
7. Bick RL, Kaplan H. Syndromes of thrombosis and hypercoagulability: congenital and acquired causes of thrombosis. Med Clin North Am 1998; 82(3):409-458.
8. De Laforcade A, Freeman LM, Shaw SP, et al. Hemostatic changes in dogs with naturally occurring sepsis. J Vet Intern Med 2003; 17(5):674-679.
9. Furie B, Furie BC. Molecular basis of blood coagulation, In: Hoffman R. ed. Hematology: Basic Principles and Practice. New York: Churchill-Livingstone; 2000, pp. 1783-1803.
10. Green RA, Thomas JS. Hemostatic disorders: coagulopathies and thrombosis, In: Ettinger SJ, Feldman EC. eds. Textbook of Veterinary Internal Medicine, 4th edn. Philadelphia: WB Saunders; 1995, pp. 1946-1963.
11. Palmer KG, King LG, Van Winkle TJ. Clinical manifestations and associated disease syndromes in dogs with cranial vena cava thrombosis: 17 cases (1989-1996). J Am Vet Med Assoc 1998; 213(2):220-224.
12. Otto CM, Rieser TM, Brooks MB, et al. Evidence of hypercoagulability in dogs with parvoviral enteritis. J Am Vet Med Assoc 2000; 217(10):1500-1504.
13. Burns MG, Kelly AB, Hornof WJ, et al. Pulmonary artery thrombosis in three dogs with hyperadrenocorticism. J Am Vet Med Assoc 1981; 178(4):388-393.
14. Green RA, Kabel AL. Hypercoagulable state in three dogs with nephrotic syndrome: role of acquired antithrombin III deficiency. J Am Vet Med Assoc 1982; 181(9):914-917.
15. Feldman BF, Madewell BR, O'Neill S. Disseminated intravascular coagulation: antithrombin, plasminogen, and coagulation abnormalities in 41 dogs. J Am Vet Med Assoc 1981; 179(2):151-154.
16. Klein MK, Dow SW, Rosychuk RAW. Pulmonary thromboembolism associated with immune-mediated hemolytic anemia in dogs: ten cases (1982-1987). J Am Vet Med Assoc 1989; 195: 246-250.
17. Hirsh J. Hypercoagulability. Semin Hematol 1977; 14(4):409-421.
18. Kutinsky I, Blakley S, et al. Normal D-dimer levels in patients with pulmonary embolism. Arch Intern Med 1999; 159(14):1569-1572.
19. Baker WF. Diagnosis of deep venous thrombosis and pulmonary embolism. Med Clin North Am 1998; 82(3):459-476.
20. Perrier A, Bounameaux H, et al. Diagnosis of pulmonary embolism by a decision analysis-based strategy including clinical probability, D-dimer levels, and ultrasonography: a management study. Arch Intern Med 1996; 136:531-536.
21. Bounameaux H, Cirafici P, et al. Measurement of D-dimer in plasma as a diagnostic aid in suspected pulmonary embolism. Lancet 1991; 337:196-200.
22. Stokol T, Brooks MB, Erb HN, et al. D-dimer concentration in healthy dogs and dogs with disseminated intravascular coagulation. Am J Vet Res 2000; 61(4):393-398.
23. Carter SJ. Rapid fibrin D-dimer tests for deep vein thrombosis: factors affecting diagnostic utility. J Emerg Med 1999; 17(4):605-610.
24. Green RA. Pathophysiology of antithrombin III deficiency. Vet Clin North Am Small Anim Pract 1988; 18(1):95-104.
25. Green RA, Kabel AL. Hypercoagulable state in three dogs with nephrotic syndrome: role of acquired antithrombin III deficiency. J Am Vet Med Assoc 1982; 1818:914-917.
26. Bick RL, Pegram M. Syndromes of hypercoagulability and thrombosis: a review. Semin Thromb Hemost 1994; 20(1):109-127.
27. Thomson C, Forbes CD, et al. Changes in blood coagulation and fibrinolysis in the nephrotic syndrome. Q J Med 1974; 171: 399-407.
28. Bick RL. Clinical relevance of antithrombin III. Semin Thromb Hemost 1982; 8(4):276-287.
29. Donahue SM
30. Ramirez PA, Deniz A, Wirth W, et al. Antithrombin III activity in healthy cats and its changes in selected diseases. Berl Munch Tierarztl Wschr 1997; 110:440-444.
31. Mallett SV, Cox DJA. Thromboelastography. Br J Anaesth 1992; 69:307-313.
32. Hartert H. Blutgerinnungstudien mit der Thrombelastographie, einern neuen Untersuchingsverfahren. Klin Wochenschr 1948; 16(37):257.
33. Chandler WL. The thromboelastograph and the thromboelastograph technique. Semin Thromb Hemost 1995; 21(S4):1-6.
34. Bowbrick VA, Mikhailidis DP, Stansby GM. The use of citrated whole blood in Thromboelastography. Anesth Analg 2000; 90(5): 1086-1088.
35. Mancuso A, Fung K, Cox D, et al. Assessment of blood coagulation in severe liver disease using thromboelastography: use of citrate storage versus native blood. Blood Coagul Fibrin 2003; 14(2): 211-216.
36. Roche AM, James MF, Grocott MP, et al. Citrated blood does not reliably reflect fresh whole blood coagulability in trials of in vitro hemodilution. Anesth Analg 2003; 96(1):58-61.
37. Traverso CI, Caprini JA, Arcelus JI. The normal thromboelastogram and its interpretation. Semin Thromb Hemost 1995; 21 (S4): 7-13.
38. Franz RC, Coetzee WJ. The thromboelastographic diagnosis of hemostatic defects. Surg Annu 1981; 13:75-107.
39. Haemoscope. Thromboelastograph® Hemostasis Analyzer User Manual. Navickes & Associates; 1999-2000, p. 7.
40. Cohen E, Caprini J, Zuckerman L, et al. Evaluation of three methods used to identify accelerated coagulability. Thromb Res 1977; 10:577-604.
41. Caprini JA, Zuckerman L, Cohen E, et al. The identification of accelerated coagulability. Thromb Res 1976; 9:167-180.
42. De Nicola P. Thrombelastography. Springfield, IL: Thomas; 1957.
43. Ammar T, Silvay G. Factors that influence early extubation: bleeding. J Cardiothorac Vasc Anesth 1998; 12(6):28-29.
44. Spiess BD, Tuman KJ, McCarthy RJ, et al. Thromboelastography as an indication of post-cardiopulmonary bypass coagulopathies. J Clin Monit 1987; 3:25-30.
45. Shore-Lesserson L, Manspeizer HE, DePerio M, et al. Thromboelastography- guided transfusion algorithm reduces transfusions in complex cardiac surgery. Anesth Analg 1999; 88:312-319.
46. Lee BY, Taha S, Trainor FS, et al. Monitoring heparin therapy with thromboelastography and activated partial thromboplastin time. World J Surg 1980; 4(3):323-330.
47. Shinoda T, Arakura H, Katakura M, et al. Usefulness of thromboelastography for dosage monitoring of low molecular weight heparin and unfractionated heparin during hemodialysis. Artif Organs 1990; 14(6):413-415.
48. Traverso CI, Caprini JA, et al. Thromboelastogram modifications induced by intravenous and subcutaneous heparin administration. Semin Thromb Hemost 1995; 21(S4):53-58.
49. Gibbs NM, Bell R. The effect of low-dose heparin on hypercoagulability following abdominal aortic surgery. Anaesth Intensive Care 1998; 26:503-508.
50. Vernese NA, Spillert CR. Thromboelastographic evaluation of mini-dose heparin in minor surgical procedures. Am Surg 1986; 2:112-113.
51. Basu D, Gallus A, Hirsh J, et al. A prospective study of the value of monitoring heparin treatment with the activated partial thromboplastin time. N Engl J Med 1972; 287(7):324-327.
52. Traverso CI, Arcelus JI, Caprini JA. Role of thromboelastography in evaluating other anticoagulant agents: warfarin and heparin-dihydroergotamine. Semin Thromb Hemost 1995; 21(S4): 59-62.
53. Hirsh J. Hypercoagulability. Semin Hematol 1977; 14(4):409.
54. Fisch IR, Freedman SH, Pellegrin FA. Effect of oral contraceptives on the thromboelastogram. Clin Pharmacol Ther 1973; 14:238-244.
55. Pivalizza EG, Pivalizza PJ, Weavind LM. Perioperative thromboelastography and sonoclot analysis in morbidly obese patients. Can J Anaesth 1997; 44(9):942-945.
56. Butler MJ. Thromboelastography during and after elective abdominal surgery. Thromb Haemost 1978; 39(2):488-495.
57. Poller L, Priest CM, Thomson JM. Platelet aggregation and strenuous exercise. J Physiol 1971; 213:525-531.
58. Pivalizza EG, Abramson DC, Harvey A. Perioperative hypercoagulability in uremic patients: a viscoelastic study. J Clin Anesth 1997; 9(6):442-445.
59. Holloway DS, Bagher JP, et al. Thromboelastography of blood from subjects with chronic renal failure. Thromb Res 1987; 45(6):817-825.
60. Kaufmann CR, Dwyer KM, Crews JD. Usefulness of thromboelastography in assessment of trauma patient coagulation. J Trauma Injury Infect Crit Care 1997; 42(4):716-722.
61. Watts DD, Trask A. Hypothermic coagulopathy in trauma: effect of varying levels of hypothermia on enzyme speed, platelet function, and fibrinolytic activity. J Trauma Injury Infect Crit Care 1998; 44(5):846-854.
62. Francis JL, Francis DA, Gunathilagan GJ. Assessment of hypercoagulability in patients with cancer using the sonoclot analyzer and thromboelastography. Thromb Res 1994; 74(4):335-346.
63. Haid M. Thromboelastographic distinction of malignant from benign breast masses: a preliminary report. South Med J 1977; 70(7):774-776.
64. Traverso CI, Caprini JA, Arceles JI. Application of thromboelastography in other medical and surgical states. Semin Thromb Hemost 1995; 21(S4):50-52.
65. Bateman SW, Mathews KA, Abrams-Ogg AC. Disseminated intravascular coagulation in dogs: review of the literature. J Vet Emerg Crit Care 1998; 8(1):29-45.
66. Raby C, Vairel E. The two-fold aspect of hypercoagulability. Gaz Med France 1967; 26:4829.
67. Karanfilian RG, Spillert CR, et al. Accelerated coagulation in a nonmetastasizing tumor in rats. Curr Surg 1981; 38(6):385-387.
68. Raina S, Spillert CR, et al. Effect of surgery on tumor-induced accelerated coagulation in a rat carcinoma. J Surg Res 1985; 38(2):138-142.
69. Haid M, Zuckerman L, et al. Thromboelastographic changes in carcinoma: an animal model. J Med 1976; 7(3-4):189-216.
70. Kaspareit J, Messow C, Edel J. Blood coagulation studies in guineapigs (Cavia porcellus). Lab Anim 1988; 22(3):206-211.
71. Burghardt WR, Goldstick TK, et al. Nonlinear viscoelasticity and the thromboelastograph: 1. Studies on bovine plasma clots. Biorheology 1995; 32(6):621-630.
72. Moalic P, Gruel Y, et al. Hemostasis development in the lamb fetus and neonate. Am J Vet Res 1989; 50(1):59-63.
73. Kraft W. Das thrombelastogramm der gesunden hauskatze und die behandlung der verbrauchskoagulopathie bei panleukopenie. Berl Munch Tierarztl Wochenschr 1973; 20:394-396.
74. Von Schaewen VH. Thromboelastographic research and thrombocyte counts in dogs. Berl Munch Tierarztl Wochenschr 1971; 17:324-328.
75. van Vliet KJ, Smit GL, et al. Thromboelastographic diagnosis of blood coagulation in two freshwater fish species. Comp Biochem Physiol 1985; 82(1):19-21.
76. van Vliet KJ, Smit GL, et al. A thromboelastographic study of the effect of stress on the blood coagulation in Cyprinus carpio (cyprinidae) and Oreochromis mossambicus (cichlidae). Comp Biochem Physiol 1985; 82(1):23-27.
77. Miller BE, Bailey JM, et al. Functional maturity of the coagulation system in children: an evaluation using thromboelastography. Anesth Analg 1997; 84:745-748.
78. Johnson LR, Lappin MR, Baker DC. Pulmonary thromboembolism in 29 dogs: 1985-1995. J Vet Intern Med 1999; 13:338-345.
79. Feldman BF, Madewll BR, O'Neill S. Disseminated intravascular coagulation: antithrombin, plasminogen, and coagulation abnormalities in 41 dogs. J Am Vet Med Assoc 1981; 179(2):151-154.
80. Johnson JT, Zuckerman L, Dunkin-Phistry G, et al. Thromboelastography used to monitor a dog with disseminated intravascular coagulation. J Am Anim Hosp Assoc 1983; 19:182-186.
81. Mockros LF, Horson SD, et al. Anticoagulant kinetics following bolus injection of heparin. Thromb Haemost 1979; 42:1248-1260.
82. Sumi H, Sasaki K, et al. Oral administration of urokinase. Thromb Res 1980; 20:711-714.